Viewing Study NCT02708602


Ignite Creation Date: 2025-12-25 @ 3:57 AM
Ignite Modification Date: 2026-02-25 @ 9:48 PM
Study NCT ID: NCT02708602
Status: UNKNOWN
Last Update Posted: 2016-03-17
First Post: 2016-02-18
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Correlation Between the Polymorphism ofβ2 AR and the Labor Progress After Labor Analgesia
Sponsor: Nanjing Maternity and Child Health Care Hospital
Organization:

Study Overview

Official Title: Principal Investigator
Status: UNKNOWN
Status Verified Date: 2016-03
Last Known Status: NOT_YET_RECRUITING
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Labor and delivery is a unique physiological experience of women. Inappropriate length of labor progress during vaginal delivery may produce great risks for mother and fetus. Especially the slow progress is one of the most important reasons for the occurrence of cesarean section during vaginal delivery, which still with a high incidence in recent years.Previous studies have found that there was a significant correlation between the genetic polymorphisms of β 2-adrenergic receptor (β2AR) and the duration of vaginal delivery.Therefore, the researchers intend to investigate the distribution of β2-adrenergic receptor (β2AR) genetic polymorphisms among Chinese parturient and observe the relationship between the genetic polymorphisms and labor process after labor analgesia.
Detailed Description: None

Study Oversight

Has Oversight DMC:
Is a FDA Regulated Drug?:
Is a FDA Regulated Device?:
Is an Unapproved Device?:
Is a PPSD?:
Is a US Export?:
Is an FDA AA801 Violation?: